OncoSec Medical Incorporated (ONCS)

US68234L4059 - Common Stock

0.2772  +0.07 (+31.87%)

After market: 0.23 -0.05 (-17.03%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-1-31)
2022
(2022-7-31)
2021
(2021-7-31)
2020
(2020-7-31)
2019
(2019-7-31)
Revenue
0.000.000.000.000.00
Operating Expenses
32.65M37.01M48.38M43.41M30.42M
Research and Development
21.77M25.82M34.10M25.10M18.45M
Selling, General, and Administrative Expenses
10.88M11.19M14.28M18.31M11.97M
Operating Income
-32.65M-37.01M-48.38M-43.41M-30.42M
Interest Income/Expense
-126.42K-530.58K-159.95K100.00K-300.00K
Other Income/Expense
56.91K28.86K-700.00190.00K440.00K
Non Recurring Items
N/A0.00960.79KN/A0.00
Income Before Taxes
-32.72M-37.51M-47.58M-43.13M-30.27M
Income Tax
-3.33M-3.33M-2.41M-870.00K0.00
Net Income
-29.39M-34.18M-45.17M-42.25M-30.28M
EBITDA
-32.40M-36.75M-48.14M-43.19M-30.18M
 
Per Share Data
EPS Diluted Total Ops
-15.24-19.13-30.20-2.56-4.29
Non GAAP EPS
N/A-19.14-31.46-63.58-94.82
 
Statistics

All data in USD

Charts